// App-Quantinova.ai

37 GP14.07 : Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Researchers

Presenter

  • Jose Javier Mediavilla

Principal Investigators

  • Diego Gonzalez-Segura

  • Antonio Perez

Medical Centers

  • Centro de Salud Burgos Rural, Burgos, Spain

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

Locations

  • Spain

Companies

  • Almirall, S.A.

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved